Covid 19, Influenza
Conditions
Brief summary
The overall project aim is to study outcomes after COVID-19 and influenza hospitalisation from 2016 - 2021 by retrieving data from the main social security carriers in Austria for the years 2010-2018
Interventions
DIAGNOSTIC_TESTPCR or antigen test for Covid 19 or Inluenza
PCR or antigen test for Covid 19 or Inluenza
Sponsors
Landesklinikum Sankt Polten
Sicknessfund Burgenland (BGKK)
A.ö. Krankenhaus St. Josef Braunau GmbH
Medical University of Vienna
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients with SARS * Patients with Covid-19 * Patients after Covid-19 * Patients with influenza
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall Mortality | 5 years | Overall mortality after influenza or covid-19 |
| age distribution | 5 years | age distribution in patients with influenza or covid-19 |
| risk profile | 5 years | risk profile (e.g. prior diseases, medication) in patients who died due to influenza or covid-19 |
| newly diagnosed diseases | 5 years | newly diagnosed diseases after influenza or covid-19 |
| newly prescribed medication | 5 years | newly prescribed medication after influenza or covid-19 |
| duration of hospitalisation or unemployability | 5 years | duration of hospitalisation or unemployability after influenza or covid-19 |
Outcome results
None listed